ZVRA logo

Zevra Therapeutics (ZVRA) Short Term Debt

Annual Short Term Debt

$38.24 M
+$37.76 M+7867.29%

31 December 2023

ZVRA Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Short Term Debt

$540.00 K
-$56.00 K-9.40%

30 September 2024

ZVRA Quarterly Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ZVRA Short Term Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+7867.3%+24.7%
3 y3 years+4201.8%+41.7%
5 y5 years+978.2%-92.4%

ZVRA Short Term Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high>+9999.0%-98.6%+48.8%
5 y5 yearsat high>+9999.0%-99.2%+90.1%
alltimeall timeat high>+9999.0%-99.2%+1587.5%

Zevra Therapeutics Short Term Debt History

DateAnnualQuarterly
Sept 2024
-
$540.00 K(-9.4%)
June 2024
-
$596.00 K(+2.2%)
Mar 2024
-
$583.00 K(-98.5%)
Dec 2023
$38.24 M(+7867.3%)
$38.24 M(+8732.1%)
Sept 2023
-
$433.00 K(-5.0%)
June 2023
-
$456.00 K(-3.0%)
Mar 2023
-
$470.00 K(-2.1%)
Dec 2022
$480.00 K(+29.4%)
$480.00 K(+1.3%)
Sept 2022
-
$474.00 K(+1.1%)
June 2022
-
$469.00 K(+29.2%)
Mar 2022
-
$363.00 K(-2.2%)
Dec 2021
$371.00 K(-58.3%)
-
Dec 2021
-
$371.00 K(-2.6%)
Sept 2021
-
$381.00 K(+11.4%)
June 2021
-
$342.00 K(-69.9%)
Mar 2021
-
$1.14 M(+28.0%)
Dec 2020
$889.00 K(+213.0%)
$889.00 K(-98.7%)
Sept 2020
-
$66.45 M(-1.7%)
June 2020
-
$67.58 M(-1.9%)
Mar 2020
-
$68.91 M(>+9900.0%)
Dec 2019
$284.00 K
$284.00 K(-96.0%)
DateAnnualQuarterly
Sept 2019
-
$7.09 M(-0.4%)
June 2019
-
$7.11 M(+5.1%)
Mar 2019
-
$6.76 M(+90.7%)
Dec 2018
$3.55 M(+0.7%)
$3.55 M(+0.1%)
Sept 2018
-
$3.54 M(+0.6%)
June 2018
-
$3.52 M(+0.1%)
Mar 2018
-
$3.52 M(-0.1%)
Dec 2017
$3.52 M(+2143.3%)
$3.52 M(+1856.7%)
Sept 2017
-
$180.00 K(+1.7%)
June 2017
-
$177.00 K(+9.3%)
Mar 2017
-
$162.00 K(+3.2%)
Dec 2016
$157.00 K(-95.4%)
$157.00 K(+49.5%)
Sept 2016
-
$105.00 K(-94.8%)
June 2016
-
$2.04 M(+22.1%)
Mar 2016
-
$1.67 M(-51.5%)
Dec 2015
$3.44 M(+309.5%)
$3.44 M(+24.4%)
Sept 2015
-
$2.76 M(+8528.1%)
June 2015
-
$32.00 K(0.0%)
Mar 2015
-
$32.00 K(-96.2%)
Dec 2014
$839.00 K(-78.4%)
$839.00 K
Dec 2013
$3.88 M
-

FAQ

  • What is Zevra Therapeutics annual short term debt?
  • What is the all time high annual short term debt for Zevra Therapeutics?
  • What is Zevra Therapeutics annual short term debt year-on-year change?
  • What is Zevra Therapeutics quarterly short term debt?
  • What is the all time high quarterly short term debt for Zevra Therapeutics?
  • What is Zevra Therapeutics quarterly short term debt year-on-year change?

What is Zevra Therapeutics annual short term debt?

The current annual short term debt of ZVRA is $38.24 M

What is the all time high annual short term debt for Zevra Therapeutics?

Zevra Therapeutics all-time high annual short term debt is $38.24 M

What is Zevra Therapeutics annual short term debt year-on-year change?

Over the past year, ZVRA annual short term debt has changed by +$37.76 M (+7867.29%)

What is Zevra Therapeutics quarterly short term debt?

The current quarterly short term debt of ZVRA is $540.00 K

What is the all time high quarterly short term debt for Zevra Therapeutics?

Zevra Therapeutics all-time high quarterly short term debt is $68.91 M

What is Zevra Therapeutics quarterly short term debt year-on-year change?

Over the past year, ZVRA quarterly short term debt has changed by +$107.00 K (+24.71%)